<DOC>
	<DOC>NCT00581243</DOC>
	<brief_summary>Randomized, inpatient, ascending multiple dose study given to subjects with schizophrenia and schizoaffective disorder to assess safety and tolerability.</brief_summary>
	<brief_title>Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Men, aged 1850 years old Women, aged 1850 years old Nonlactating women, aged 1850 years old Nonpregnant women, aged 1850 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Safety,Tolerability, Schizophrenia</keyword>
</DOC>